Concepedia

Katherine Chi-Burris

KC

Statistics

Publications

5

Citations

265

H-Index

5

Active since

2006

Affiliations

Pfizer (United States)(Current)

University of Utah

University College London

Jupiter Medical Center

Quark Pharmaceuticals (United States)

Katherine Chi-Burris is an author at Pfizer (United States) specializing in medicine, ophthalmology, and pharmacotherapy.

Publications per year

2006–2013

5

Publications

5

Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Investigative Ophthalmology & Visual Science · 2012 · 101 citations

, , +16

Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Ophthalmology · 2012 · 82 citations

, , +9

Comparison of Latanoprost and Timolol in Pediatric Glaucoma: A Phase 3, 12-Week, Randomized, Double-Masked Multicenter Study

Tomoko Maeda‐Chubachi, Katherine Chi-Burris, Brad D. Simons et al. · Ophthalmology · 2011 · 42 citations

, , +14

Switching immunosuppression medications after renal transplantation—a common practice

Herwig‐Ulf Meier‐Kriesche, Alice Chu, Kristin M. David et al. · Nephrology Dialysis Transplantation · 2006 · 29 citations · Full text

, , +9

Impact of Age, Diagnosis, and History of Glaucoma Surgery on Outcomes in Pediatric Patients Treated With Latanoprost

Tomoko Maeda‐Chubachi, Katherine Chi-Burris, Brad D. Simons et al. · Journal of Glaucoma · 2013 · 11 citations

, , +17

1–5 of 5